Results for tag: "Human Plasma Derived Therapeutic"

The Human Plasma Derived Therapeutic market is a subset of the pharmaceutical industry that focuses on the development and production of drugs derived from human plasma. These drugs are used to treat a variety of conditions, including autoimmune diseases, hemophilia, and other blood disorders. Plasma-derived therapies are also used to treat certain types of cancer, as well as to provide immunoglobulins for the prevention of infections. The Human Plasma Derived Therapeutic market is highly regulated, with stringent safety and efficacy standards in place to ensure the quality of the drugs produced. Companies in this market must adhere to Good Manufacturing Practices (GMP) and must meet the requirements of the US Food and Drug Administration (FDA). Some of the major companies in the Human Plasma Derived Therapeutic market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. These companies are involved in the development, production, and distribution of plasma-derived therapies. Show Less Read more